Tenet Healthcare (NYSE: THC): Investment Analysis and Stock Performance Outlook

• BMO Capital initiated coverage on Tenet Healthcare with a "Market Perform" rating, suggesting its stock performance is expected to align with broader market trends.
• Tenet Healthcare is forecasted to report a significant 24.05% increase in Earnings Per Share (EPS) to $4.59, indicating potential for an earnings beat.
• The company maintains a robust market capitalization of approximately $21.1 billion, with analysts projecting full-year earnings of $21.04 per share and revenue of $22.2 billion.

Tenet Healthcare (NYSE: THC) is a diversified healthcare services company that operates a network of hospitals and outpatient centers. The company provides a range of medical services to communities across the United States. It operates in a competitive medical sector that includes companies like Aveanna Healthcare (NASDAQ: AVAH).

On September 22, 2026, investment firm BMO Capital initiated coverage on Tenet Healthcare with a "Market Perform" grade. This rating suggests the stock performance is expected to perform in line with the broader market. At the time of the announcement, the stock price was $262.06. This follows a recent session where Tenet Healthcare closed down 1.38%, underperforming the S&P 500.

Despite the neutral rating, there are positive expectations for the company's financial results. As highlighted by Zacks Investment Research, Tenet Healthcare is a stock that may deliver an earnings beat, which is when a company reports profits higher than analysts predict. The company is forecasted to report an Earnings Per Share (EPS) of $4.59, a 24.05% increase from the prior year.

Recent insider trading activity shows Director Nadja West sold 1,152 shares on September 2, 2026, for approximately $298,138.00. This sale represented 5% of her direct holdings. Following the transaction, she retains a significant direct stake in the company valued at approximately $6.1 million.

Currently, Tenet Healthcare has a market capitalization, or total company value, of about $21.1 billion. Over the past 52 weeks, the stock has traded between a low of $157.58 and a high of $283.05. For the full year, analysts expect earnings of $21.04 per share and revenue of $22.2 billion.